Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
89 studies found for:    1273
Show Display Options
Rank Status Study
1 Recruiting Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
Conditions: Human Papillomavirus Infection;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: Docetaxel;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Hyperfractionation;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis
2 Completed Long-Term Predictors of Morbidity in Older Age
Conditions: Cardiovascular Diseases;   Diabetes Mellitus;   Heart Diseases;   Heart Failure;   Heart Failure, Congestive;   Obesity
Intervention:
3 Completed Physical Activity and Nutritional Education as School-based Interventions to Control Obesity in Children and Adolescents
Conditions: OVERWEIGHT;   OBESITY
Intervention: Behavioral: Physical Activity and Nutrition Education
4 Recruiting Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma
Conditions: Pancreatic Cancer;   Periampullary Adenocarcinoma
Intervention: Radiation: Stereotactic Body Radiation Therapy (SBRT)
5 Recruiting Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Sagramostim;   Drug: Saline -- placebo comparator
6 Recruiting Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism by 18F-DTBZ PET
Condition: Parkinson's Disease
Intervention: Drug: 18F-DTBZ
7 Completed The Effect of Combined Thermal and Electrical Muscle Stimulation (cTEMS) on Obesity
Condition: Obesity
Intervention: Device: combined thermal and electrical muscle stimulation (cTEMS)
8 Not yet recruiting Chronic Opioid Use in Low Back Pain and Lumbar Orthosis Intervention
Conditions: Chronic Lower Back Pain;   Chronic Pain;   Opioid Tolerance
Interventions: Device: In-elastic lumbar brace;   Device: Elastic abdominal binder
9 Unknown  ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
Condition: Malignant Mesothelioma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ranpirnase
10 Active, not recruiting Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
Conditions: Brain Tumors;   Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: temozolomide;   Procedure: adjuvant therapy;   Radiation: radiation therapy
11 Unknown  Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
Condition: Breast Cancer
Interventions: Drug: AC regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel
12 Completed Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: filgrastim;   Drug: gemcitabine hydrochloride;   Drug: vinorelbine tartrate
13 Unknown  Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
Conditions: Chemotherapeutic Agent Toxicity;   Colorectal Cancer;   Neuropathy;   Neurotoxicity
Interventions: Drug: calcium gluconate;   Drug: magnesium sulfate;   Other: placebo
14 Active, not recruiting Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
Conditions: Brain Tumor;   Central Nervous System Tumor
Interventions: Drug: cisplatin;   Drug: cyclophosphamide;   Drug: lomustine;   Drug: vincristine sulfate;   Radiation: radiation therapy
15 Active, not recruiting Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: dexamethasone;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: pegaspargase;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate;   Radiation: radiation therapy
16 Recruiting Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
Condition: Prostate Cancer
Interventions: Behavioral: telephone-based intervention;   Other: counseling intervention;   Other: educational intervention;   Procedure: therapeutic dietary intervention
17 Withdrawn Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Genetic: DNA analysis;   Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: high performance liquid chromatography;   Other: laboratory biomarker analysis
18 Recruiting Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Condition: Colorectal Cancer
Interventions: Drug: celecoxib;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Other: placebo
19 Unknown  Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Conditions: Neurotoxicity Syndromes;   Pain;   Peripheral Neuropathy;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: duloxetine hydrochloride;   Other: placebo
20 Active, not recruiting Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: topotecan hydrochloride;   Drug: Isotretinoin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years